<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37766091</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Immune Response after SARS-CoV-2 Infection with Residual Post-COVID Symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1413</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines11091413</ELocationID><Abstract><AbstractText>Many patients develop post-acute COVID syndrome (long COVID (LC)). We compared the immune response of LC and individuals with post-COVID full recovery (HC) during the Omicron pandemic. Two hundred ninety-two patients with confirmed COVID infections from January to May 2022 were enrolled. We observed anti-SARS-CoV-2 receptor-binding domain immunoglobulin G, surrogate virus neutralization test, T cell subsets, and neutralizing antibodies against Wuhan, BA.1, and BA.5 viruses (NeuT). NeuT was markedly reduced against BA.1 and BA.5 in HC and LC groups, while antibodies were more sustained with three doses and an updated booster shot than &#x2264;2-dose vaccinations. The viral neutralization ability declined at &gt;84-days after COVID-19 onset (PC) in both groups. PD1-expressed central and effector memory CD4<sup>+</sup> T cells, and central memory CD8<sup>+</sup> T cells were reduced in the first months PC in LC. Therefore, booster vaccines may be required sooner after the most recent infection to rescue T cell function for people with symptomatic LC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pongkunakorn</LastName><ForeName>Tanyaporn</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9886-1102</Identifier><AffiliationInfo><Affiliation>Siriraj Population Health and Nutrition Research Group, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manosan</LastName><ForeName>Thamonwan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Siriraj Population Health and Nutrition Research Group, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surawit</LastName><ForeName>Apinya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3094-5481</Identifier><AffiliationInfo><Affiliation>Siriraj Population Health and Nutrition Research Group, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ophakas</LastName><ForeName>Suphawan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Siriraj Population Health and Nutrition Research Group, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongkolsucharitkul</LastName><ForeName>Pichanun</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3971-935X</Identifier><AffiliationInfo><Affiliation>Siriraj Population Health and Nutrition Research Group, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pumeiam</LastName><ForeName>Sureeporn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Siriraj Population Health and Nutrition Research Group, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suta</LastName><ForeName>Sophida</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Siriraj Population Health and Nutrition Research Group, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinsawas</LastName><ForeName>Bonggochpass</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Siriraj Population Health and Nutrition Research Group, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sookrung</LastName><ForeName>Nitat</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saelim</LastName><ForeName>Nawannaporn</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahasongkram</LastName><ForeName>Kodchakorn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prangtaworn</LastName><ForeName>Pannathee</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tungtrongchitr</LastName><ForeName>Anchalee</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangjittipokin</LastName><ForeName>Watip</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-7103-8466</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangmee</LastName><ForeName>Suthee</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0989-6857</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boonnak</LastName><ForeName>Kobporn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7536-8964</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narkdontri</LastName><ForeName>Tassanee</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teerawattanapong</LastName><ForeName>Nipaporn</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanitphadeedecha</LastName><ForeName>Rungsima</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayurasakorn</LastName><ForeName>Korapat</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3816-6463</Identifier><AffiliationInfo><Affiliation>Siriraj Population Health and Nutrition Research Group, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R016534004</GrantID><Agency>The Faculty of Medicine, Siriraj Hospital, Mahidol University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">breakthrough infection</Keyword><Keyword MajorTopicYN="N">immunogenicity</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neutralizing antibody</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37766091</ArticleId><ArticleId IdType="pmc">PMC10535557</ArticleId><ArticleId IdType="doi">10.3390/vaccines11091413</ArticleId><ArticleId IdType="pii">vaccines11091413</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tuekprakhon A., Nutalai R., Dijokaite-Guraliuc A., Zhou D., Ginn H.M., Selvaraj M., Liu C., Mentzer A.J., Supasa P., Duyvesteyn H.M.E., et al. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185:2422&#x2013;2433.e13. doi: 10.1016/j.cell.2022.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9181312</ArticleId><ArticleId IdType="pubmed">35772405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemaitelly H., Tang P., Coyle P., Yassine H.M., Al-Khatib H.A., Smatti M.K., Hasan M.R., Ayoub H.H., Altarawneh H.N., Al-Kanaani Z., et al. Protection against Reinfection with the Omicron BA.2.75 Subvariant. N. Engl. J. Med. 2023;388:665&#x2013;667. doi: 10.1056/NEJMc2214114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2214114</ArticleId><ArticleId IdType="pmc">PMC9878583</ArticleId><ArticleId IdType="pubmed">36652342</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpa F., Sanna D., Benvenuto D., Borsetti A., Azzena I., Casu M., Fiori P.L., Giovanetti M., Maruotti A., Ceccarelli G., et al. Genetic and structural data on the SARS-CoV-2 omicron BQ.1 variant reveal its low potential for epidemiological expansion. Int. J. Mol. Sci. 2022;23:15264. doi: 10.3390/ijms232315264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232315264</ArticleId><ArticleId IdType="pmc">PMC9739521</ArticleId><ArticleId IdType="pubmed">36499592</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Thailand  COVID-19&#x2014;WHO Thailand Situation Reports.  [(accessed on 30 April 2023)].  Available online:  https://www.who.int/thailand/emergencies/novel-coronavirus-2019/situation-reports.</Citation></Reference><Reference><Citation>UK Health Security Agency . SARS-CoV-2 Variants of Concern and Variants under Investigation in England: Technical Briefing 49. UK Health Security Agency; London, UK: 2023.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention . Monitoring Variant Proportions. U.S. Department of Health &amp; Human Services&#x2014;CDC; Atlanta, GA, USA: 2023.</Citation></Reference><Reference><Citation>Mongkolsucharitkul P., Surawit A., Pumeiam S., Sookrung N., Tungtrongchitr A., Phisalprapa P., Sayabovorn N., Srivanichakorn W., Washirasaksiri C., Auesomwang C., et al. SARS-CoV-2 antibody response against mild-to-moderate breakthrough COVID-19 in home isolation setting in Thailand. Vaccines. 2022;10:1131. doi: 10.3390/vaccines10071131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071131</ArticleId><ArticleId IdType="pmc">PMC9318962</ArticleId><ArticleId IdType="pubmed">35891295</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., Ballouz T., Menges D., Hasler S., Adamo S., Raeber M.E., B&#xe4;chli E., Rudiger A., et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat. Commun. 2022;13:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho T., Krammer F., Iwasaki A. The first 12 months of COVID-19: A timeline of immunological insights. Nat. Rev. Immunol. 2021;21:245&#x2013;256. doi: 10.1038/s41577-021-00522-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00522-1</ArticleId><ArticleId IdType="pmc">PMC7958099</ArticleId><ArticleId IdType="pubmed">33723416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Malorni W. Long COVID: To investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur. Respir. J. 2022;59:2102245. doi: 10.1183/13993003.02245-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02245-2021</ArticleId><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., Walshaw C., Kemp S., Corrado J., Singh R., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaksi N., Teker A.G., Imre A. Long COVID in hospitalized COVID-19 patients: A retrospective cohort study. Iran. J. Public Health. 2022;51:88&#x2013;95. doi: 10.18502/ijph.v51i1.8297.</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijph.v51i1.8297</ArticleId><ArticleId IdType="pmc">PMC8837882</ArticleId><ArticleId IdType="pubmed">35223629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z., Yang M., Lai C.L. Long COVID-19 syndrome: A comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. 2021;9:966. doi: 10.3390/biomedicines9080966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus.  [(accessed on 5 November 2021)].  Available online:  https://apps.who.int/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf.</Citation></Reference><Reference><Citation>Sugiyama A., Miwata K., Kitahara Y., Okimoto M., Abe K., Bunthen E., Ouoba S., Akita T., Tanimine N., Ohdan H., et al. Long COVID occurrence in COVID-19 survivors. Sci. Rep. 2022;12:6039. doi: 10.1038/s41598-022-10051-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10051-z</ArticleId><ArticleId IdType="pmc">PMC8996498</ArticleId><ArticleId IdType="pubmed">35411017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson B.A., Visvabharathy L., Ali S.T., Kang A.K., Patel T.R., Clark J.R., Lim P.H., Orban Z.S., Hwang S.S., Mattoon D., et al. Plasma biomarkers of neuropathogenesis in hospitalized patients with COVID-19 and those with postacute sequelae of SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1151. doi: 10.1212/NXI.0000000000001151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001151</ArticleId><ArticleId IdType="pmc">PMC8901169</ArticleId><ArticleId IdType="pubmed">35256481</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L., Hanson B., Orban Z., Lim P.H., Palacio N.M., Jain R., Clark J.R., Graham E.L., Liotta E.M., Penaloza-MacMaster P., et al. Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein. Front. Immunol. 2023;14:1155770. doi: 10.3389/fimmu.2023.1155770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1155770</ArticleId><ArticleId IdType="pmc">PMC10258318</ArticleId><ArticleId IdType="pubmed">37313412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascellino M.T., Di Timoteo F., De Angelis M., Oliva A. Overview of the main anti-SARS-CoV-2 vaccines: Mechanism of action, efficacy and safety. Infect. Drug Resist. 2021;14:3459&#x2013;3476. doi: 10.2147/IDR.S315727.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S315727</ArticleId><ArticleId IdType="pmc">PMC8418359</ArticleId><ArticleId IdType="pubmed">34511939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirijatuphat R., Suputtamongkol Y., Angkasekwinai N., Horthongkham N., Chayakulkeeree M., Rattanaumpawan P., Koomanachai P., Assanasen S., Rongrungruang Y., Chierakul N., et al. Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand&#x2019;s university-based referral hospital. BMC Infect. Dis. 2021;21:382. doi: 10.1186/s12879-021-06081-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06081-z</ArticleId><ArticleId IdType="pmc">PMC8072093</ArticleId><ArticleId IdType="pubmed">33902480</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranha C., Patel V., Bhor V., Gogoi D. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients. J. Med. Virol. 2021;93:6794&#x2013;6797. doi: 10.1002/jmv.27206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27206</ArticleId><ArticleId IdType="pmc">PMC8426941</ArticleId><ArticleId IdType="pubmed">34264527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury D.S., Cromer D., Reynaldi A., Schlub T.E., Wheatley A.K., Juno J.A., Subbarao K., Kent S.J., Triccas J.A., Davenport M.P. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 2021;27:1205&#x2013;1211. doi: 10.1038/s41591-021-01377-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01377-8</ArticleId><ArticleId IdType="pubmed">34002089</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbarao K., McAuliffe J., Vogel L., Fahle G., Fischer S., Tatti K., Packard M., Shieh W.J., Zaki S., Murphy B. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 2004;78:3572&#x2013;3577. doi: 10.1128/JVI.78.7.3572-3577.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.7.3572-3577.2004</ArticleId><ArticleId IdType="pmc">PMC371090</ArticleId><ArticleId IdType="pubmed">15016880</ArticleId></ArticleIdList></Reference><Reference><Citation>Houser K.V., Gretebeck L., Ying T., Wang Y., Vogel L., Lamirande E.W., Bock K.W., Moore I.N., Dimitrov D.S., Subbarao K. Prophylaxis with a middle east respiratory syndrome coronavirus (MERS-CoV)-specific human monoclonal antibody protects rabbits from MERS-CoV infection. J. Infect. Dis. 2016;213:1557&#x2013;1561. doi: 10.1093/infdis/jiw080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw080</ArticleId><ArticleId IdType="pmc">PMC4837915</ArticleId><ArticleId IdType="pubmed">26941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedhammer C., Halbritter D., Weissert R. Peripheral blood mononuclear cells: Isolation, freezing, thawing, and culture. In: Weissert R., editor. Multiple Sclerosis: Methods and Protocols. Springer; New York, NY, USA: 2016. pp. 53&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">25092056</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Li R., Li Y., Yang H., Zhou L., Yuan J., Pan T., Liu B., Zhang H., He Y. Antibody response and cross-neutralization after Omicron BA.2 infection. Signal Transduct. Target. Ther. 2023;8:25. doi: 10.1038/s41392-022-01305-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01305-3</ArticleId><ArticleId IdType="pmc">PMC9823246</ArticleId><ArticleId IdType="pubmed">36611028</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Benzouak T., Gunpat S., Burns R.J., Tahir T.A., Jolles S., Kisely S. Fatigue symptoms associated with COVID-19 in convalescent or recovered COVID-19 patients; a systematic review and meta-analysis. Ann. Behav. Med. 2022;56:219&#x2013;234. doi: 10.1093/abm/kaab081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abm/kaab081</ArticleId><ArticleId IdType="pmc">PMC8574547</ArticleId><ArticleId IdType="pubmed">34665858</ArticleId></ArticleIdList></Reference><Reference><Citation>de Erausquin G.A., Snyder H., Carrillo M., Hosseini A.A., Brugha T.S., Seshadri S. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimer&#x2019;s Dement. 2021;17:1056&#x2013;1065. doi: 10.1002/alz.12255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12255</ArticleId><ArticleId IdType="pmc">PMC10431934</ArticleId><ArticleId IdType="pubmed">33399270</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi T., Harada K. Immune response to SARS-CoV-2 in severe disease and long COVID-19. iScience. 2022;25:104723. doi: 10.1016/j.isci.2022.104723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104723</ArticleId><ArticleId IdType="pmc">PMC9251893</ArticleId><ArticleId IdType="pubmed">35813874</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm L.K., Nielsen S.S.F., Pahus M.H., Frattari G.S., Olesen R., Andersen R., Monrad I., Andersen A.H.F., Thomsen M.M., Konrad C.V., et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. eBioMedicine. 2021;64:103230. doi: 10.1016/j.ebiom.2021.103230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103230</ArticleId><ArticleId IdType="pmc">PMC7847186</ArticleId><ArticleId IdType="pubmed">33530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Long COVID syndrome-associated brain fog. J. Med. Virol. 2022;94:979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., Sarkar S., Fram T.R., Boppana S., Sterrett S., Qin K., Bansal A., Long D.M., Sabbaj S., Kobie J.J., et al. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses. JCI Insight. 2021;6:e151544. doi: 10.1172/jci.insight.151544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.151544</ArticleId><ArticleId IdType="pmc">PMC8410022</ArticleId><ArticleId IdType="pubmed">34143754</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Lu P., Dhodapkar R.M., Gehlhausen J.R., Tabachnikova A., Tabacof L., Malik A.A., Kamath K., et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv. 2022 doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Zhang M., Zhu T., Zhili N., Liu Z., Xiang R., Zhang W., Xu Y. Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19. Int. J. Infect. Dis. 2020;98:353&#x2013;358. doi: 10.1016/j.ijid.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7334931</ArticleId><ArticleId IdType="pubmed">32634585</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M., Guo Y., Luo Q., Huang Z., Zhao R., Liu S., Le A., Li J., Wan L. T-cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of coronavirus disease 2019. J. Infect. Dis. 2020;222:198&#x2013;202. doi: 10.1093/infdis/jiaa252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa252</ArticleId><ArticleId IdType="pmc">PMC7239156</ArticleId><ArticleId IdType="pubmed">32379887</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Li S., Liu J., Liang B., Wang X., Wang H., Li W., Tong Q., Yi J., Zhao L., et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. eBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102763</ArticleId><ArticleId IdType="pmc">PMC7165294</ArticleId><ArticleId IdType="pubmed">32361250</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamanickam A., Pavan Kumar N., Pandiaraj A.N., Selvaraj N., Munisankar S., Renji R.M., Venkataramani V., Murhekar M., Thangaraj J.W.V., Muthusamy S.K., et al. Characterization of memory T cell subsets and common &#x3b3;-chain cytokines in convalescent COVID-19 individuals. J. Leukoc. Biol. 2022;112:201&#x2013;212. doi: 10.1002/JLB.5COVA0721-392RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5COVA0721-392RR</ArticleId><ArticleId IdType="pmc">PMC9088480</ArticleId><ArticleId IdType="pubmed">35258122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M., Chroscicki P., Swatler J., Stepnik D., De Biasi S., Hampel M., Brewinska-Olchowik M., Maliszewska A., Sklinda K., Durlik M., et al. Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection. Front. Immunol. 2022;13:886431. doi: 10.3389/fimmu.2022.886431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham N., Eisenhauer P., Diehl S.A., Pierce K.K., Whitehead S.S., Durbin A.P., Kirkpatrick B.D., Sette A., Weiskopf D., Boyson J.E., et al. Rapid induction and maintenance of virus-specific CD8(+) T(EMRA) and CD4(+) T(EM) cells following protective vaccination against dengue virus challenge in humans. Front. Immunol. 2020;11:479. doi: 10.3389/fimmu.2020.00479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00479</ArticleId><ArticleId IdType="pmc">PMC7105617</ArticleId><ArticleId IdType="pubmed">32265929</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B., Wang C., Tan Y., Chen X., Liu Y., Ning L., Chen L., Li M., Liu Y., Wang G., et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) Front. Immunol. 2020;11:827. doi: 10.3389/fimmu.2020.00827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Larbi A., Fulop T. From "truly na&#xef;ve" to "exhausted senescent" T cells: When markers predict functionality. Cytom. A. 2014;85:25&#x2013;35. doi: 10.1002/cyto.a.22351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.22351</ArticleId><ArticleId IdType="pubmed">24124072</ArticleId></ArticleIdList></Reference><Reference><Citation>Salumets A., Tserel L., Rumm A.P., T&#xfc;rk L., Kingo K., Saks K., Oras A., Uibo R., Tamm R., Peterson H., et al. Epigenetic quantification of immunosenescent CD8(+) TEMRA cells in human blood. Aging Cell. 2022;21:e13607. doi: 10.1111/acel.13607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13607</ArticleId><ArticleId IdType="pmc">PMC9124311</ArticleId><ArticleId IdType="pubmed">35397197</ArticleId></ArticleIdList></Reference><Reference><Citation>Loretelli C., Abdelsalam A., D&#x2019;Addio F., Ben Nasr M., Assi E., Usuelli V., Maestroni A., Seelam A.J., Ippolito E., Di Maggio S., et al. PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response. JCI Insight. 2021;6:e146701. doi: 10.1172/jci.insight.146701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.146701</ArticleId><ArticleId IdType="pmc">PMC8783674</ArticleId><ArticleId IdType="pubmed">34784300</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha M.S., Jeong H.W., Ko J.H., Choi S.J., Seo I.H., Lee J.S., Sa M., Kim A.R., Joo E.J., Ahn J.Y., et al. PD-1-expressing SARS-CoV-2-specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19. Immunity. 2021;54:44&#x2013;52.e3. doi: 10.1016/j.immuni.2020.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7834198</ArticleId><ArticleId IdType="pubmed">33338412</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M., Gao Y., Wang G., Song G., Liu S., Sun D., Xu Y., Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell. Mol. Immunol. 2020;17:533&#x2013;535. doi: 10.1038/s41423-020-0402-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Blot M., Bour J.B., Quenot J.P., Bourredjem A., Nguyen M., Guy J., Monier S., Georges M., Large A., Dargent A., et al. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome. J. Transl. Med. 2020;18:457. doi: 10.1186/s12967-020-02646-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02646-9</ArticleId><ArticleId IdType="pmc">PMC7711269</ArticleId><ArticleId IdType="pubmed">33272291</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilevskaya A., Mushtaque A., Tsang M.Y., Alwazan B., Herridge M., Cheung A.M., Tartaglia M.C. Sex and age affect acute and persisting COVID-19 illness. Sci. Rep. 2023;13:6029. doi: 10.1038/s41598-023-33150-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33150-x</ArticleId><ArticleId IdType="pmc">PMC10098246</ArticleId><ArticleId IdType="pubmed">37055492</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G., Goldoni M., Solinas E., Cavalli C., Tagliaferri S., Ranzieri S., Frizzelli A., Marchi L., Mori P.A., Majori M., et al. Sex-related differences in long-COVID-19 syndrome. J. Women&#x2019;s Health. 2022;31:620&#x2013;630. doi: 10.1089/jwh.2021.0411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2021.0411</ArticleId><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>